Clinical trial
Safety of Larazotide Acetate in Healthy Volunteers
NCT00386490 · 9 Meters Biopharma, Inc., Industry · Completed
Key facts
| NCT number | NCT00386490 |
|---|---|
| Title | Safety of Larazotide Acetate in Healthy Volunteers |
| Official title | A Phase 1, Randomized, Double-Blind, Placebo Controlled, Multi-Dose Study to Determine the Safety, Tolerance and Pharmacokinetics of 3 Dose Levels of Larazotide Acetate (AT-1001) in Healthy Volunteers |
| Lead sponsor | 9 Meters Biopharma, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | larazotide acetate |
| Enrollment | 24 |
| Start date | Jan 10, 2006 |
| Primary completion | Feb 27, 2006 |
| Completion | Feb 27, 2006 |
| First posted | Oct 11, 2006 |
| Last update posted | Sep 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: